Interestingly, pancreatic cancer cells exhibit compensatory metabolic networks that sustain progression after GLS inhibition.174 When GLS1 was inhibited in pancreatic tumors, the GLS2 pathway was upregulated for Glu production.175. The gene discussed is GLS2; the disease is pancreatic neoplasm.